Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2019-05-23
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of a Series of Systemic Cryotherapy Treatments on the Functional State of Patients With Multiple Sclerosis
NCT04533971
Impact of Multiple Sclerosis From the Viewpoint of the Caregivers
NCT02388334
Exercise on Multiple Sclerosis Patients
NCT04125628
Impact of the Modifications of Environmental Exposures and Health Care Access During COVID-19 Lockdown on Multiple Sclerosis
NCT05033782
An Observational Study to Assess the Quality of Life of the Patients With Multiple Sclerosis and Their Caregivers
NCT01075737
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treated group by thermal cure
Treated group will benefit, within 6 weeks of the inclusion, from the thermal cure in one of the thermal establishments.
Spa therapy
The standardized treatment will consist of 4 spa treatments per day for 3 consecutive weeks.
Each day, the patient receives at least four treatments, among which:
* Cure of Drink (in addition to 4 daily cares)
* Bath in running water: Bath
* Bath in running water: Pool at 32 ° C
* Bath with aerobain
* Immersion shower bath
* Shower of high pressure under immersion in swimming pool
* General penetrating shower
* General jet shower
* Local jet shower
* Local mud bath at the feet
* Single poultice
* Multiple poultice
* Compress
* Mobilization pool
* Massages under water
Control group
Control group will receive a thermal cure after the end of the study
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spa therapy
The standardized treatment will consist of 4 spa treatments per day for 3 consecutive weeks.
Each day, the patient receives at least four treatments, among which:
* Cure of Drink (in addition to 4 daily cares)
* Bath in running water: Bath
* Bath in running water: Pool at 32 ° C
* Bath with aerobain
* Immersion shower bath
* Shower of high pressure under immersion in swimming pool
* General penetrating shower
* General jet shower
* Local jet shower
* Local mud bath at the feet
* Single poultice
* Multiple poultice
* Compress
* Mobilization pool
* Massages under water
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Showing EDSS \<7 severity criteria
* Patient with MS for whom an indication of spa treatment has been made,
* Patient agreeing to participate in this study and therefore accepting the constraints related to the design "immediate cure-deferred cure",
* Patient receiving the general social security scheme,
* Patient having given written consent to participate in the study
* Patient with relapsing remitting MS
* Patient unfit according to the investigator to complete the rating scales
* Patient with heat intolerance called "Uhthoff effect"
* Patient with a contraindication to the spa treatment: urinary or faecal leakage, wound, thrombophlebitis less than three months old, unstabilized cardio respiratory disease.
* Patient with serious life-threatening condition (ie, cancer)
* Patient under tutorship or curatorship
* Patient participating in another interventional clinical research project
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association Francaise pour la Recherche Thermale
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Département de Médecine Physique et de Réadaptation, Hopital LAPEYRONIE
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A02411-54
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.